Accelerating Innovation: Complexity, Regulation, and Temporality
This Perspective paper explores recent moves seen in many countries toward accelerating the speed at which biomedical innovation can be delivered to the clinic. It discusses the drivers behind this and the rationale for it, illustrating this briefly in the field of regenerative medicine. It argues t...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2019-03-01
|
| Series: | Frontiers in Sociology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/article/10.3389/fsoc.2019.00013/full |
| _version_ | 1819097815017586688 |
|---|---|
| author | Andrew Webster |
| author_facet | Andrew Webster |
| author_sort | Andrew Webster |
| collection | DOAJ |
| description | This Perspective paper explores recent moves seen in many countries toward accelerating the speed at which biomedical innovation can be delivered to the clinic. It discusses the drivers behind this and the rationale for it, illustrating this briefly in the field of regenerative medicine. It argues that the process reconfigures present/future relations, especially in terms of the relationship between different forms of evidence and risk calculations. The regulatory/innovation relationship is, as a result, being rewritten. Paradoxically, the moves toward acceleration are less to do with the arrival of a more streamlined evaluation system that selects for scientifically robust technologies ready for “the market.” In contrast, it reflects the growing complexity of innovation itself: whereas Latour (1987) had argued that “science-in the-making” was backstage in contrast to “ready-made science,” the former is now very visible. This in turn has generated two other parallel processes—“regulation-in-the-making” and “risk-in-the-making.” Such shifts can be seen in the field of regenerative medicine. The paper asks how best to engage with the move toward acceleration and thereby the future oversight of innovation. |
| first_indexed | 2024-12-22T00:21:05Z |
| format | Article |
| id | doaj.art-9200707f6ca94d04a74b6db236322a5c |
| institution | Directory Open Access Journal |
| issn | 2297-7775 |
| language | English |
| last_indexed | 2024-12-22T00:21:05Z |
| publishDate | 2019-03-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Sociology |
| spelling | doaj.art-9200707f6ca94d04a74b6db236322a5c2022-12-21T18:45:10ZengFrontiers Media S.A.Frontiers in Sociology2297-77752019-03-01410.3389/fsoc.2019.00013419494Accelerating Innovation: Complexity, Regulation, and TemporalityAndrew WebsterThis Perspective paper explores recent moves seen in many countries toward accelerating the speed at which biomedical innovation can be delivered to the clinic. It discusses the drivers behind this and the rationale for it, illustrating this briefly in the field of regenerative medicine. It argues that the process reconfigures present/future relations, especially in terms of the relationship between different forms of evidence and risk calculations. The regulatory/innovation relationship is, as a result, being rewritten. Paradoxically, the moves toward acceleration are less to do with the arrival of a more streamlined evaluation system that selects for scientifically robust technologies ready for “the market.” In contrast, it reflects the growing complexity of innovation itself: whereas Latour (1987) had argued that “science-in the-making” was backstage in contrast to “ready-made science,” the former is now very visible. This in turn has generated two other parallel processes—“regulation-in-the-making” and “risk-in-the-making.” Such shifts can be seen in the field of regenerative medicine. The paper asks how best to engage with the move toward acceleration and thereby the future oversight of innovation.https://www.frontiersin.org/article/10.3389/fsoc.2019.00013/fullaccelerationinnovationregulationriskregenerative medicine |
| spellingShingle | Andrew Webster Accelerating Innovation: Complexity, Regulation, and Temporality Frontiers in Sociology acceleration innovation regulation risk regenerative medicine |
| title | Accelerating Innovation: Complexity, Regulation, and Temporality |
| title_full | Accelerating Innovation: Complexity, Regulation, and Temporality |
| title_fullStr | Accelerating Innovation: Complexity, Regulation, and Temporality |
| title_full_unstemmed | Accelerating Innovation: Complexity, Regulation, and Temporality |
| title_short | Accelerating Innovation: Complexity, Regulation, and Temporality |
| title_sort | accelerating innovation complexity regulation and temporality |
| topic | acceleration innovation regulation risk regenerative medicine |
| url | https://www.frontiersin.org/article/10.3389/fsoc.2019.00013/full |
| work_keys_str_mv | AT andrewwebster acceleratinginnovationcomplexityregulationandtemporality |